Correction: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
Year: 2026
Type: erratum
Authors: Eileen Shinn, David Zahrieh, Angela DeMichele, Nick Zdenkowski, Julie Lemieux, Jun Mao, Vesna Bjelic-Radisic, Michelle J. Naughton, Georg Pfeiler, Karen Gelmon, Justin M. Balko, Daniel Egle, Gabriele Zoppoli, Tiffany Traina, Miguel Martin Jimenez, Silvia Antolin Novoa, Tufia Haddad, Arlene Chan, Alistair Ring, Antonio Wolff, William Fraser Symmans, Jose Ponce Lorenzo, Dhanusha Sabanathan, Hal J. Burstein, Zbigniew Ireneusz Nowecki, Gunda Pristauz-Telsnigg, Adam Brufsky, Meritxell Bellet-Ezquerra, Theodoros Foukakis, Yelena Novik, Gabor Rubovszky, Christian F. Singer, Karoline Muehlbacher, Otto Metzger Filho, Theodora Goulioti, Ernest Law, Ann H. Partridge, Lisa A. Carey, Alex Zoroufy, Dominik Hlauschek, Christian Fesl, Erica L. Mayer, Michael Gnant
Institutions: The University of Texas MD Anderson Cancer Center, Mayo Clinic, Eastern Cooperative Oncology Group, University of Pennsylvania, University of Newcastle Australia, Centre hospitalier universitaire de Québec, Université Laval, Memorial Sloan Kettering Cancer Center, Witten/Herdecke University, Medical University of Graz, Helios Universitätsklinikum Wuppertal, The Ohio State University, Comprehensive Cancer Center Vienna, Austrian Breast & Colorectal Cancer Study Group, Medical University of Vienna, University of British Columbia, Vanderbilt University Medical Center, Innsbruck Medical University, Ospedale Policlinico San Martino, University of Genoa, Universidad Complutense de Madrid, Hospital General Universitario Gregorio Marañón, GEICAM – Spanish Breast Cancer Group, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Johns Hopkins University, Hospital General Universitario de Alicante Doctor Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Nepean Hospital, Dana-Farber Cancer Institute, The Maria Sklodowska-Curie National Research Institute of Oncology, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Vall d'Hebron Institute of Oncology, Karolinska Institutet, New York University, National Institute of Oncology, Breast International Group, Pfizer (United States), University of North Carolina at Chapel Hill
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W7130372232